People

Anthony Aiudi

Anthony Aiudi

Anthony Aiudi is identified by Neutrolis as both its current chief executive officer and a Morningside investor. His professional background spans biotechnology investment and company development. This Morningside role is recorded as concurrent with his published operating appointment; cumulative personal investment activity is not a firm fund close.

Roles

Morningside Ventures

Investor (concurrent operating affiliation)

Current